BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28761897)

  • 21. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
    Okubo L; Andrick B; Rampulla R; Leri F
    J Oncol Pharm Pract; 2022 Jun; 28(4):898-903. PubMed ID: 35156879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
    Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
    Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
    Biron P; Fuhrmann C; Cure H; Viens P; Lefebvre D; Thyss A; Viot M; Soler-Michel P; Rollin C; Grès JJ
    J Antimicrob Chemother; 1998 Oct; 42(4):511-8. PubMed ID: 9818751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
    Kwon KT; Cheong HS; Rhee JY; Wi YM; Ryu SY; Heo ST; Moon CS; Ki HK; Kim KH; Jung CW; Peck KR; Song JH
    Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial.
    Engervall P; Kalin M; Dornbusch K; Björkholm M
    J Chemother; 1999 Aug; 11(4):278-86. PubMed ID: 10465130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
    Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
    Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
    Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis.
    Adderson EE; Flynn PM; Hoffman JM
    J Pediatr; 2010 Sep; 157(3):490-5, 495.e1. PubMed ID: 20434167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
    Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
    Cometta A; Glauser MP
    J Chemother; 1996 Oct; 8(5):375-81. PubMed ID: 8957718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefepime monotherapy for febrile neutropenia in patients with lung cancer.
    Saito H; Takahashi K; Okuno M; Saka H; Imaizumi K; Hasegawa Y; Tanikawa Y; Yamamoto M; Taniguchi H; Shindoh J; Suzuki R; Shimokata K;
    J Infect Chemother; 2014 Jun; 20(6):365-9. PubMed ID: 24679653
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.